Fiona
Analyst
Jefferies
Equibles does not estimate personal net worth.
About Fiona
Fiona is recorded as Analyst at Jefferies. Fiona has spoken on 3 earnings calls and 2 other investor events across 5 companies, most recently for MBX Biosciences, Inc. on June 3, 2026. Those appearances were for MBX Biosciences, Inc. (MBX), Autolus Therapeutics plc (AUTL), BioAge Labs, Inc. (BIOA), JELD-WEN Holding, Inc. (JELD) and Armstrong World Industries Inc (AWI). The companies whose calls Fiona spoke on are classified in the Healthcare and Industrials sectors.
Fiona on recent calls
“I cover spring cap biotech companies at Jeffrey's, and it is my greatest pleasure to welcome to the stage with me MBX Bioscience CEO, Ken Harlock, and CMO, Dr. Sam Osley.”
“This is day one of Jeffrey's Global Healthcare Conference. My name is Fiona. I cover SMICAP, biotech companies at Jeffrey's. And it is my greatest pleasure to welcome to this fireside chat with me from Atalus Therapeutics CEO, Christian Aitem.”
“My question is also somewhat related to the dose response between the 60 and 120. Is it possible that you're hitting an efficacy ceiling even at 60 because both response seems to be good.”
“We saw the volumes on North America were much better than expected.”
“How do you expect the recent tariff on steel and aluminum to impact your wave earnings in 2025? Just wondering do you have the ability to push price higher?”
Affiliation history
-
Jefferies
Analyst
Transcript header (unverified)
Current
Company network
BioAge Labs, Inc.
BIOA
Drug Manufacturers - Specialty & Generic · Healthcare
1 appearance
Latest appearance 2026-04-21
View calls and events
Building Products & Equipment · Industrials
1 appearance
Latest appearance 2025-08-06
View calls and events
Building Products & Equipment · Industrials
1 appearance
Latest appearance 2025-02-25
View calls and events